Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epithelium, Corneal | 4 | 2009 | 10 | 0.900 |
Why?
|
| Multidrug Resistance-Associated Proteins | 3 | 2009 | 47 | 0.800 |
Why?
|
| Cornea | 2 | 2009 | 81 | 0.540 |
Why?
|
| Patents as Topic | 1 | 2014 | 14 | 0.430 |
Why?
|
| Ophthalmic Solutions | 1 | 2014 | 18 | 0.420 |
Why?
|
| Thiosemicarbazones | 1 | 2012 | 10 | 0.390 |
Why?
|
| Iron Chelating Agents | 1 | 2012 | 21 | 0.380 |
Why?
|
| Drug Delivery Systems | 1 | 2014 | 273 | 0.350 |
Why?
|
| Nanoparticles | 2 | 2014 | 449 | 0.340 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 458 | 0.330 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2009 | 83 | 0.290 |
Why?
|
| Quinolines | 4 | 2009 | 76 | 0.270 |
Why?
|
| Antiviral Agents | 1 | 2009 | 189 | 0.260 |
Why?
|
| Neoplasm Proteins | 1 | 2009 | 228 | 0.260 |
Why?
|
| Antihypertensive Agents | 1 | 2009 | 285 | 0.250 |
Why?
|
| Eye Proteins | 1 | 2006 | 63 | 0.250 |
Why?
|
| Membrane Transport Proteins | 1 | 2006 | 98 | 0.250 |
Why?
|
| Pharmaceutical Preparations | 1 | 2006 | 93 | 0.230 |
Why?
|
| Rabbits | 4 | 2010 | 292 | 0.220 |
Why?
|
| Propionates | 3 | 2009 | 27 | 0.210 |
Why?
|
| Gene Expression Regulation | 1 | 2009 | 1066 | 0.200 |
Why?
|
| Biological Transport | 3 | 2009 | 201 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2009 | 649 | 0.190 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2009 | 1112 | 0.170 |
Why?
|
| Permeability | 3 | 2010 | 66 | 0.160 |
Why?
|
| Cells, Cultured | 3 | 2009 | 1617 | 0.150 |
Why?
|
| Dogs | 2 | 2009 | 201 | 0.130 |
Why?
|
| Erythromycin | 2 | 2006 | 14 | 0.130 |
Why?
|
| Delayed-Action Preparations | 2 | 2014 | 72 | 0.120 |
Why?
|
| Blotting, Western | 2 | 2009 | 884 | 0.120 |
Why?
|
| Aniline Compounds | 1 | 2015 | 27 | 0.110 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2015 | 44 | 0.110 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2015 | 122 | 0.110 |
Why?
|
| Histone Deacetylases | 1 | 2015 | 61 | 0.110 |
Why?
|
| Cell Line | 2 | 2009 | 1416 | 0.110 |
Why?
|
| Drug Discovery | 1 | 2015 | 106 | 0.100 |
Why?
|
| Animals | 6 | 2014 | 16695 | 0.100 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2014 | 93 | 0.100 |
Why?
|
| Isomerism | 1 | 2012 | 65 | 0.100 |
Why?
|
| Caco-2 Cells | 1 | 2012 | 59 | 0.100 |
Why?
|
| Cell Membrane Permeability | 1 | 2012 | 57 | 0.090 |
Why?
|
| Isoquinolines | 1 | 2012 | 50 | 0.090 |
Why?
|
| Limit of Detection | 1 | 2012 | 82 | 0.090 |
Why?
|
| Humans | 7 | 2015 | 42163 | 0.080 |
Why?
|
| Iron | 1 | 2012 | 247 | 0.080 |
Why?
|
| Macular Edema | 1 | 2010 | 5 | 0.080 |
Why?
|
| Polyglycolic Acid | 1 | 2010 | 48 | 0.080 |
Why?
|
| Steroids | 1 | 2010 | 45 | 0.080 |
Why?
|
| Cloprostenol | 1 | 2009 | 3 | 0.080 |
Why?
|
| Prostaglandins F, Synthetic | 1 | 2009 | 6 | 0.080 |
Why?
|
| Acyclovir | 1 | 2009 | 7 | 0.080 |
Why?
|
| Acridines | 1 | 2009 | 1 | 0.080 |
Why?
|
| Acetanilides | 1 | 2009 | 3 | 0.080 |
Why?
|
| Mitoxantrone | 1 | 2009 | 3 | 0.080 |
Why?
|
| Lactic Acid | 1 | 2010 | 110 | 0.080 |
Why?
|
| Adenine | 1 | 2009 | 48 | 0.080 |
Why?
|
| Cell Transformation, Viral | 1 | 2009 | 22 | 0.080 |
Why?
|
| Area Under Curve | 1 | 2009 | 95 | 0.080 |
Why?
|
| Cell Survival | 1 | 2012 | 934 | 0.070 |
Why?
|
| Models, Biological | 1 | 2012 | 711 | 0.070 |
Why?
|
| Simian virus 40 | 1 | 2009 | 38 | 0.070 |
Why?
|
| Drug Resistance, Multiple | 1 | 2009 | 28 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2012 | 1058 | 0.070 |
Why?
|
| Tetrahydroisoquinolines | 1 | 2009 | 22 | 0.070 |
Why?
|
| Pyrroles | 1 | 2009 | 68 | 0.070 |
Why?
|
| Amides | 1 | 2009 | 72 | 0.070 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2009 | 385 | 0.070 |
Why?
|
| Indoles | 1 | 2009 | 178 | 0.070 |
Why?
|
| Ketoconazole | 1 | 2006 | 8 | 0.070 |
Why?
|
| Cyclosporine | 1 | 2006 | 36 | 0.060 |
Why?
|
| Bioprosthesis | 1 | 2005 | 6 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 2598 | 0.060 |
Why?
|
| Aortic Diseases | 1 | 2005 | 34 | 0.060 |
Why?
|
| Heart Valve Prosthesis | 1 | 2005 | 45 | 0.060 |
Why?
|
| Calcium-Binding Proteins | 1 | 2005 | 80 | 0.060 |
Why?
|
| Calcinosis | 1 | 2005 | 61 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2006 | 400 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2005 | 164 | 0.050 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2005 | 142 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2009 | 1265 | 0.050 |
Why?
|
| Gene Expression | 1 | 2006 | 692 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2006 | 426 | 0.050 |
Why?
|
| Calcium | 1 | 2005 | 487 | 0.050 |
Why?
|
| Proteins | 1 | 2005 | 383 | 0.050 |
Why?
|
| Male | 2 | 2009 | 22779 | 0.040 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2015 | 98 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2015 | 118 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 462 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2015 | 875 | 0.020 |
Why?
|
| Dialysis | 1 | 2010 | 7 | 0.020 |
Why?
|
| Sclera | 1 | 2010 | 6 | 0.020 |
Why?
|
| Prednisolone | 1 | 2010 | 16 | 0.020 |
Why?
|
| Emulsions | 1 | 2010 | 35 | 0.020 |
Why?
|
| Gels | 1 | 2010 | 43 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2010 | 55 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2010 | 92 | 0.020 |
Why?
|
| Hydrocortisone | 1 | 2010 | 89 | 0.020 |
Why?
|
| Temperature | 1 | 2010 | 314 | 0.020 |
Why?
|
| Kinetics | 1 | 2010 | 698 | 0.020 |
Why?
|
| Equipment Failure Analysis | 1 | 2005 | 45 | 0.010 |
Why?
|
| Tissue Culture Techniques | 1 | 2005 | 36 | 0.010 |
Why?
|